Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001129928-12-000013
Filing Date
2012-03-23
Accepted
2012-03-23 13:36:40
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F oncy-201112x31x20f.htm 20-F 1699540
2 EXHIBIT 4.19 ex419gkinnealemploymentagr.htm EX-4.HTM 99125
3 EXHIBIT 4.18 georgegillemploymentagreem.htm EX-4.HTM 92975
4 EXHIBIT 8.0 ex80listofsubsidiaries.htm EX-8.HTM 4385
5 EXHIBIT 12.1 oncy-ex121_20111231x20f.htm EX-12.HTM 14728
6 EXHIBIT 12.2 oncy-ex122_20111231x20f.htm EX-12.HTM 13449
7 EXHIBIT 13.1 oncy-ex131_20111231x20f.htm EX-13.HTM 7253
8 EXHIBIT 13.2 oncy-ex132_20111231x20f.htm EX-13.HTM 6163
9 EXHIBIT 15.1 ex151-2011mda.htm EX-15.HTM 434228
10 EXHIBIT 15.2 ex152eyconsentletter.htm EX-15.HTM 4558
11 GRAPHIC ernstyounglogo.jpg GRAPHIC 6545
12 GRAPHIC onclogo.jpg GRAPHIC 32654
13 GRAPHIC reovirus.jpg GRAPHIC 86821
  Complete submission text file 0001129928-12-000013.txt   2551478
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-31062 | Film No.: 12711327
SIC: 2834 Pharmaceutical Preparations